retatrutide and blood pressure 🚨 may have just changed the obesity treatment landscape., New Phase 3 data reported:, ✅ 28.7% average weight loss, ✅ 72% reversal of prediabetes, ✅ 86% reduction in liver fat, ✅ ~14 mmHg Beyond glycemia: Comparing tirzepatide Metabolic & Appetite-Regulating Size:2 x 450 GM

retatrutide and blood pressure 🚨 may have just changed the obesity treatment landscape., New Phase 3 data reported:, ✅ 28.7% average weight loss, ✅ 72% reversal of prediabetes, ✅ 86% reduction in liver fat, ✅ ~14 mmHg Beyond glycemia: Comparing tirzepatide Metabolic & Appetite-Regulating Size:2 x 450 GM

Beyond glycemia: Comparing tirzepatide to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders | Springer Nature Link

Reduces nausea and that "sour stomach" feeling

Metabolic & Appetite-Regulating

Size:2 x 450 GM

Heavyweight impact of GLP-1 drugs transcends biomanufacturing The success of GLP-1s is reshaping pharma and biotech, from acquisitions to emerging competitors